amitriptyline has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"We describe an MS patient who developed migraine headaches, which followed a specific pattern coincident with interferon-beta administration." | 1.33 | Migraines linked to interferon-beta treatment of multiple sclerosis. ( Fast, A; Khromov, A; Nissinoff, J; Segal, M, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Khromov, A | 1 |
Segal, M | 1 |
Nissinoff, J | 1 |
Fast, A | 1 |
1 other study available for amitriptyline and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
Migraines linked to interferon-beta treatment of multiple sclerosis.
Topics: Adult; Amitriptyline; Analgesics, Non-Narcotic; Female; Humans; Interferon-beta; Migraine Disorders; | 2005 |